Françoise Degoul

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Topics

Radical Prostatectomy

Basal Cell Carcinoma

Monoclonal Antibody

Metabolic Syndrome

Top Venues

Cancer immunology, immunotherapy : CII

Scientific reports

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Erwan Bouchareb, Sarah Dallel, Angélique De Haze, Christelle Damon-Soubeyrand, Yoan Renaud, Elissa Baabdaty, Marine Vialat, Julien Fabre, Pierre Pouchin, Cyrille De Joussineau, Françoise Degoul, Swapnil Ganesh Sanmukh, Juliette Gendronneau, Phelipe Sanchez, Céline Gonthier-Gueret, Amalia Trousson, Laurent Morel, Jean Marc A Lobaccaro, Ayhan Kocer, Silvère Baron
Liver X Receptors Enhance Epithelial to Mesenchymal Transition in Metastatic Prostate Cancer Cells. Cancers 16 (16) (2024)
Erwan Bouchareb, Sarah Dallel, Angélique De Haze, Christelle Damon-Soubeyrand, Yoan Renaud, Elissa Baabdaty, Marine Vialat, Julien Fabre, Pierre Pouchin, Cyrille De Joussineau, Françoise Degoul, Swapnil Ganesh Sanmukh, Juliette Gendronneau, Phelipe Sanchez, Céline Gonthier-Gueret, Amalia Trousson, Laurent Morel, Jean Marc A Lobaccaro, Ayhan Kocer, Silvère Baron
Liver X Receptors Enhance Epithelial to Mesenchymal Transition in Metastatic Prostate Cancer Cells. Cancers 16 (16) (2024)
Maria Noelia Chao, Jean-Michel Chezal, Eric Debiton, Damien Canitrot, Tiffany Witkowski, Sophie Levesque, Françoise Degoul, Sébastien Tarrit, Barbara Wenzel, Elisabeth Miot-Noirault, Audrey Serre, Aurélie Maisonial-Besset
A Convenient Route to New (Radio)Fluorinated and (Radio)Iodinated Cyclic Tyrosine Analogs. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Hussein Akil, Mercedes Quintana, Jeremy H Raymond, Tommy Billoux, Valentin Benboubker, Sophie Besse, Philippe Auzeloux, Véronique Delmas, Valérie Petit, Lionel Larue, Michel D'Incan, Françoise Degoul, Jacques Rouanet
Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma. Cancers 13 (6) (2021)
Aurélie Rondon, Jacques Rouanet, Françoise Degoul
Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials. Cancers 13 (21) (2021)
Jacques Rouanet, Valentin Benboubker, Hussein Akil, Ana Hennino, Philippe Auzeloux, Sophie Besse, Bruno Pereira, Solène Delorme, Sandrine Mansard, Michel D'Incan, Françoise Degoul, Paul-Olivier Rouzaire
Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy. Cancer immunology, immunotherapy : CII 69 (10) (2020)
Manale El Kharbili, Muriel Cario-Andre, Nicolas Béchetoille, Catherine Pain, Claude Boucheix, Françoise Degoul, Ingrid Masse, Odile Berthier-Vergnes
Tspan8 Drives Melanoma Dermal Invasion by Promoting ProMMP-9 Activation and Basement Membrane Proteolysis in a Keratinocyte-Dependent Manner. Cancers 12 (5) (2020)
Mathilde Bonnet, Aurélie Maisonial-Besset, Yingying Zhu, Tiffany Witkowski, Gwenaëlle Roche, Claude Boucheix, Céline Greco, Françoise Degoul
Targeting the Tetraspanins with Monoclonal Antibodies in Oncology: Focus on Tspan8/Co-029. Cancers 11 (2) (2019)
Aurélie Rondon, Nancy Ty, Jean-Baptiste Bequignat, Mercedes Quintana, Arnaud Briat, Tiffany Witkowski, Bernadette Bouchon, Claude Boucheix, Elisabeth Miot-Noirault, Jean-Pierre Pouget, Jean-Michel Chezal, Isabelle Navarro-Teulon, Emmanuel Moreau, Françoise Degoul
Antibody PEGylation in bioorthogonal pretargeting with trans-cyclooctene/tetrazine cycloaddition: in vitro and in vivo evaluation in colorectal cancer models. Scientific reports 7 (1) (2017)